LONDON, Dec 16 (Reuters) - The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less ...

LONDON, Dec 16 (Reuters) - The U.S. health regulator has approved GSK's add-on drug to treat severe asthma, the drugmaker ...

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.

It's full steam ahead for a new Regeneron facility in Saratoga Springs. The company has learned that Saratoga County's ...

Pharma marketers are still getting up to speed on the changing health data privacy landscape. Here’s how they can develop ...

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along ...

Several headwinds have pushed Regeneron 's (NASDAQ: REGN) shares lower over the past year and a half. However, the company is bouncing back and has performed well in recent months. What's more, there ...

Sanofi (NASDAQ:SNY) is a French pharmaceutical firm that has been at the center of several analysts’ attention lately.

ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling 'unprecedented.' Major pharmaceutical developers such as ...

At this year’s American College of Allergy, Asthma & Immunology Scientific Meeting, Anne K. Ellis, MD, MSc, FACAAI, received ...

The biotechnology sector is characterized by significant price swings, and Regeneron Pharmaceuticals is currently navigating one such period. Although the co ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...